查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844170

按产品类型、应用、最终用户、技术和患者类型分類的血液分离设备市场—2025-2032年全球预测

Apheresis Equipment Market by Product Type, Application, End User, Technology, Patient Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血液分离设备市场将成长至 64.5 亿美元，复合年增长率为 9.34%。

主要市场统计数据
基准年 2024 31.5亿美元
预计年份：2025年 34.5亿美元
预测年份：2032年 64.5亿美元
复合年增长率 (%) 9.34%

为血液分离设备的发展奠定基础：影响采购和临床应用的临床驱动因素、技术选择和营运现实

血液分离设备处于临床照护、细胞治疗创新和捐赠者管理的交汇点，影响血液成分和治疗性细胞的采集、处理和输送方式。系统自动化、耗材设计和病原体控制的最新进展拓展了设备的功能范围，使CAR-T细胞疗法和干细胞疗法的细胞采集流程更加精准，同时支持可扩展的血浆捐献和治疗性血液分离术。同时，应用场所的多样化——从专科医院和血液中心到研究机构和社区诊所——推动了对更多样化的设备外形和服务模式的需求，并日益重视易用性、安全性和与临床实验室的下游整合。

实际上，相关人员平衡资本投入与日常耗材需求，将技术选择与临床方案和病患类型结合，并维持关键套件和配件的供应链连续性。离心机和膜平台等技术选择会影响自动化程度、处理量和临床人员培训，并持续影响工作流程设计。包括综合医院和专科医院、血站以及学术和商业研究实验室在内的最终用户在选择设备时，会优先考虑可靠性、供应商支援和临床证据。同时，监管监测和捐赠者安全要求也会影响不同地区设备的接受度和临床应用。这些因素共同作用，使得血液分离设备在技术上既复杂又具有重要的战略意义，对医疗机构、製造商和研究机构都至关重要。

自动化、病原体控制和分散式护理模式的快速发展如何重新定义设备设计、服务预期和临床工作流程

一系列变革正在重塑血液分离术的格局，这些变革超越了产品渐进式升级，彻底改变了整个医疗管道和经营模式。细胞治疗计画的激增提升了专用细胞采集流程的重要性，并推动了分离系统和耗材的创新，以支持CAR-T细胞和干细胞应用的高细胞存活率和温和操作。同时，病原体灭活技术的进步正在重新定义血浆采集和输注流程的安全标准，并增强设备性能与血站操作规程之间的一致性。

自动化和软体主导的流程控制正在将以往的手动步骤标准化，从而减少操作人员的差异并缩短培训时间。因此，全自动和半自动离心机及膜分离技术正吸引不同类型的买家，他们的需求取决于处理量和临床复杂性。此外，分散式医疗模式和即时供体检测的兴起正促使供应商设计更紧凑、互通性的系统，以便在诊所环境中部署。法律规范和报销管道也在不断发展，为临床应用开闢了新的途径，同时也对临床证据和上市后监测提出了更高的要求。最后，供应链韧性和环境永续性正成为策略重点，影响着套件和配件的材料选择，并促使製造商重新思考物流和供应商关係。这些转变正在加速从销售独立产品向提供整合服务和解决方案的转变，这些服务和解决方案将仪器、耗材和数据主导的支援相结合。

检验关税主导的进口压力对整个生态系统的供应链、采购选择和采购时间表的营运和策略影响。

由于近期政策週期中实施的关税措施，影响血液分离设备采购的政策环境发生了显着变化，迫使企业重新评估其采购、库存和生产布局。关税主导的进口零件和成品系统成本压力，凸显了供应商多元化和近岸外包策略的重要性，采购团队需要在单位成本、交货日期确定性和供应商长期可靠性之间权衡取舍。对许多相关人员，这意味着在供应商资质审核方面采取更加谨慎的态度，更加关注零件来源、供应商财务韧性以及应对未来贸易中断的合约保障措施。

临床医生和医院采购部门已采取措施，延长关键耗材（尤其是易受供应链波动影响的一次性试剂套件和配件）的库存前置作业时间。同时，製造商加快了寻找替代供应来源的步伐，在可行的情况下投资本地生产能力，并重新设计包装和物流，以减轻关税的影响。由于专用细胞分离系统和病原体灭活耗材的前置作业时间延长，因此需要儘早制定采购计画和紧急应变计画。

监管机构和合规团队目前必须权衡营运需求（即供应来源多元化）与本地註册要求和品质保证标准，以确保替代来源符合相同的临床和安全标准。总体而言，关税压力正推动医疗器材製造商、零件供应商和最终用户之间加强合作，以提高供应链透明度，增加关键SKU的库存，并维持医疗保健的连续性和临床研究的进度。

详细的細項分析揭示了产品类型、临床应用、最终用户画像和技术选择如何相互交织，从而创造差异化和价值。

了解血液分离设备市场需要深入了解产品类型、应用、终端用户、技术和患者群体。不同的产品，例如血液分离试剂套件及配件、细胞分离系统、病原体惰性系统和血浆分离系统，其采购週期和收入模式各不相同。一次性试剂套件等耗材通常能带来持续的收入来源，并需要完善的物流；而资本密集的分离设备则需要长期的服务和培训投入。细胞采集，包括CAR-T细胞采集和干细胞采集，需要针对细胞活力、处理速度和封闭式工作流程进行优化的系统；而血浆捐献渠道（从单份血浆到来源血浆）则优先考虑处理能力、捐献者舒适度和病原体灭活能力。研究和治疗性血液分离分别对文件和性能有特定的要求，这些要求会影响设备的配置和售后支援。

终端用户构成了另一个差异化维度。血液中心规模庞大，需要可重复的捐血流程和严格的监管报告；诊所通常需要紧凑易用的平台来支持小批量项目；而医院，无论是综合医院还是专科医院，都需要在急诊需求和手术流程效率之间取得平衡。研究机构分为学术机构和商业机构，需要专门的实验通讯协定接口，并与製造商密切合作进行检验和客製化。在技​​术方面，离心式和膜分离式方法各有优劣。离心式平台有全自动和半自动两种类型，通常强调封闭式系统操作和成熟的临床人体工学设计；而膜分离式系统，包括批次和连续流模式，可以提供模组化设计，并针对特定应用提供不同的性能范围。最后，成人和儿童患者群体的划分会影响设备配置、耗材规格和临床培训重点，因此製造商和医疗机构需要相应调整方案和配套材料。整合这些细分因素有助于开发有针对性的产品，并制定符合临床实际情况的商业性化服务策略。

基础设施、监管和临床重点的区域差异将决定全球市场的采用曲线、采购行为和伙伴关係需求。

区域动态，源自于医疗基础设施、管理体制、捐赠模式和临床重点领域的差异，显着影响血液分离设备的采用、支持和规模化应用。在美洲，健全的临床网路、细胞治疗检测的高普及率以及完善的血站基础设施，自然地催生了对先进细胞分离系统和整合耗材供应链的需求。该地区的采购流程往往侧重于供应商的服务能力、临床培训项目以及在高通量中心久经考验的运作可靠性。相反，欧洲、中东和非洲的情况更为复杂，协调的监管环境、国家血液服务模式以及波动的医疗支出影响这些地区的采用模式。儘管集中式医疗体系和国家采购机制通常倾向于标准化平台和长期服务协议，但该地区的新兴市场则需要成本优化的解决方案和灵活的部署模式。

亚太地区机会与挑战并存。各大城市和研究中心正迅速提升细胞治疗计画和大规模血浆采集能力，从而推动了对自动化分离设备和病原体灭活技术的需求。同时，各国不同的监管时间表、区域性生产激励措施和报销机制也导致技术应用速度不一。在整个亚太地区，在地化的供应链、临床培训和售后服务能力对于技术的持续应用仍然至关重要。区域相关人员越来越重视能够提供全面解决方案的伙伴关係，这些方案不仅包括设备，还包括培训、耗材供应保障以及数据主导的支持，以优化临床效率和保障捐血者安全。

技术差异化、耗材生态系统和卓越服务如何决定设备供应商的竞争优势和伙伴关係关係优先事项

设备製造商、耗材供应商和服务供应商之间的竞争动态取决于技术差异化、售后市场收入导向和临床支援能力。市场领导往往会大力投资其耗材生态系统（一次性试剂套件和配件），这不仅能确保持续的需求，还能提高终端用户的转换成本。同时，随着医院和血站寻求能够减少操作人员差异并简化培训流程的供应商，软体工具、自动化程度和整合临床支援服务等方面的差异化正成为采购谈判中的决定性因素。

製造商与研究机构之间的合作正在加速细胞采集系统的创新週期，尤其是针对CAR-T细胞和干细胞疗法的客製化系统。策略伙伴关係、共同开发契约和临床试验支援安排有助于弥合实验室方法与可扩展临床工作流程之间的差距。此外，在执行时间直接影响临床吞吐量和捐赠者保留率的市场中，提供​​强大全球服务网路（包括本地零件供应和快速回应的技术支援）的公司将获得竞争优势。长期策略，包括投资本地製造、采用可逐步升级的模组化产品架构以及永续性，正变得越来越重要。总而言之，这些方法共同建构了一个竞争格局，在这个格局中，技术性能、服务品质和供应安全与设备规格同等重要。

製造商和供应商可采取的切实可行的策略重点，以增强供应链韧性、加速临床应用并获得持续的收入来源。

为了掌握临床和商业机会，产业领导者应采取多管齐下的策略，兼顾短期营运韧性和长期创新。首先，应优先考虑关键耗材的供应链透明度和冗余性，具体措施包括：对多家供应商进行资格认证、优化一次性套件库存策略，以及评估区域生产或按需付费模式，以减少进口中断的影响。其次，应投资自动化和软体功能，提高细胞采集和血浆捐赠流程的效率和临床一致性，从而减少操作人员的差异并缩短训练週期。第三，应开发模组化产品架构，使客户无需更换整个系统即可升级功能，例如病原体灭活模组或增强型资料接口，从而提高产品生命週期价值并简化采购决策。

此外，我们将透过支持研究者主导的临床试验以及与学术和商业研究机构的合作开发项目，加强临床伙伴关係。这些合作将加速新通讯协定的检验，并建立支持其应用的证据库。从商业性角度来看，我们将透过提供包含资本设备、耗材订阅和基于绩效的服务承诺的捆绑式方案，使我们的定价模式与最终用户的经济效益相符。从监管角度来看，我们将协调在主要司法管辖区的申报工作，并制定健全的上市后监测策略，以满足不断变化的安全预期。最后，我们将把永续性和循环经济的考量纳入产品设计和物流规划，以应对日益增长的环境和采购要求，同时清晰地向客户传达这些努力，使其成为机构采购决策中的差异化优势。

透过对临床访谈、技术文件、监管记录和采购分析进行严格的三角验证，确保了基于证据的洞察和业务相关性。

本执行摘要的分析结合了针对血液分离设备技术和操作特性而製定的一手和二手证据。一手研究包括对来自医院、血站、诊所和研究机构的临床使用者进行结构化访谈，以及与设备工程师、供应链经理和法规专家进行讨论，以了解实际应用中的挑战和供应商绩效的考量。二手研究则查阅了设备手册、监管申报文件、临床实验室註册资讯、同行评审文献和技术白皮书，以检验性能声明、追踪技术发展并评估其与临床通讯协定的一致性。

补充资讯包括分析采购模式和服务模式、审查专利格局以识别创新趋势，以及考察影响组件采购和物流的政策和贸易趋势。在适用情况下，我们比较了离心式和膜分离技术的技术规范，以了解自动化能力和耗材用量。所有研究结果均透过多方交叉资讯来源进行三角检验，以确保其可靠性和对决策者的相关性。在整个研究过程中，我们专注于临床应用性和操作可行性，而非推测性预测，最终得出的见解旨在为采购、研发优先排序和策略伙伴关係提供资讯。

整合临床、技术和营运方面的必要因素，从而确定实现持久性血液分离设备应用和商业性成功的路径。

技术进步和临床需求正在推动新的系统功能和服务模式的出现，而政策和供应链压力则正在重塑采购和生产选择。自动化、改进的病原体控制和客製化耗材设计的整合，使得更安全、更有效率的工作流程成为可能，从而支持高通量血浆采集和敏感细胞治疗采集。同时，关税驱动的进口动态和区域监管差异凸显了製定积极主动的供应链策略和本地支援能力的重要性。

显然，对于价值链上的所有相关人员而言，将产品开发与临床工作流程相契合、透过可靠的物流和培训确保耗材的持续收入，以及投资于能够加速临床检验的伙伴关係关係至关重要。透过将技术性能与强大的服务产品和持续的供应相结合，製造商和供应商可以提供既满足当前营运需求又满足长期临床目标的解决方案。对于那些以整体视角看待医疗器材——将其视为包含耗材、软体、临床证据和服务在内的生态系统的一部分——的组织而言，未来的道路是畅通的。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在血球分离术工作流程中采用自动化细胞处理和人工智慧驱动的最佳化
  • 在全球健康危机的背景下，对康復期血浆采集设备的需求正在上升。
  • 向适用于远端和移动环境的可携式和照护现场血液分离系统的过渡
  • 增加一次性试剂套件的使用，以降低交叉感染的风险
  • 亚太地区新兴的血液分离术市场成长主要得益于医疗保健政策的支持。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 依产品类型分類的血液分离设备市场

  • 血浆分离术套件及配件
  • 细胞分离系统
  • 病原体灭活系统
  • 电浆分离系统

第九章 按应用分類的血液分离设备市场

  • 细胞收集
    • CAR T 细胞采集
    • 干细胞采集
  • 血浆捐献
    • 单份血浆
    • 提供来源血浆
  • 研究用途
  • 治疗性血液分离术

第十章 按最终用户分類的血液分离设备市场

  • 血液中心
  • 诊所
  • 医院
    • 综合医院
    • 专科医院
  • 研究所
    • 学术机构
    • 商业实验室

第十一章 按技术分類的血液分离设备市场

  • 离心技术
    • 全自动系统
    • 半自动系统
  • 膜技术
    • 批次处理系统
    • 连续流系统

第十二章 依病患类型分類的血液分离设备市场

  • 成人
  • 孩子们

第十三章 区域血液分离设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的血液分离设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国血液分离设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Terumo Blood and Cell Technologies, Inc.
    • Haemonetics Corporation
    • Fresenius Kabi AG
    • Macopharma SAS
    • B. Braun Melsungen AG
    • Miltenyi BIoTec GmbH
    • Grifols, SA
    • Asahi Kasei Medical Co., Ltd.
    • Cerus Corporation
    • Fenwal, Inc.
Product Code: MRR-ED54C46E8736

The Apheresis Equipment Market is projected to grow by USD 6.45 billion at a CAGR of 9.34% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.15 billion
Estimated Year [2025] USD 3.45 billion
Forecast Year [2032] USD 6.45 billion
CAGR (%) 9.34%

Setting the scene for apheresis equipment: clinical drivers, technology choices, and operational realities shaping procurement and clinical adoption

Apheresis equipment sits at the intersection of clinical care, cellular therapy innovation, and donor management, shaping how blood components and therapeutic cells are collected, processed, and delivered. Recent advances in system automation, consumable design, and pathogen mitigation have expanded the functional scope of devices, enabling more precise cell collection workflows for CAR T and stem cell therapies, while supporting scalable plasma donation and therapeutic apheresis procedures. Concurrently, the diversification of settings-from specialized hospitals and blood centers to research institutes and community clinics-has driven demand for a wider array of device form factors and service models, with a growing emphasis on usability, safety, and downstream integration with clinical laboratories.

In practical terms, stakeholders must balance capital procurement with recurring consumable needs, integrate technology choices that align with clinical protocols and patient types, and maintain supply chain continuity for critical kits and accessories. Technology choices such as centrifugal and membrane platforms continue to influence workflow design, with implications for automation level, throughput, and clinical staff training. End users including general and specialty hospitals, blood centers, and both academic and commercial research institutes prioritize reliability, vendor support, and clinical evidence when selecting equipment. Meanwhile, regulatory scrutiny and donor safety requirements shape device acceptance and clinical uptake across geographies. Taken together, these forces make the apheresis equipment environment both technically complex and strategically consequential for providers, manufacturers, and research organizations.

How rapid advances in automation, pathogen control, and decentralized care models are redefining device design, service expectations, and clinical workflows

The apheresis landscape is being reshaped by a set of transformative shifts that extend beyond incremental product upgrades to alter entire care pathways and business models. The surge in cell therapy programs has elevated the importance of dedicated cell collection workflows, prompting innovation in separator systems and consumables that support high-viability yields and gentle handling for CAR T and stem cell applications. At the same time, improvements in pathogen inactivation technologies are redefining safety expectations for plasma collection and transfusion workflows, prompting greater alignment between device capabilities and blood center protocols.

Automation and software-driven process control are enabling previously manual steps to be standardized, which reduces operator variability and shortens training timelines. As a consequence, full and semi-automation options within centrifugal and membrane technology families are attracting different types of buyers based on throughput needs and clinical complexity. Additionally, a move toward decentralized models of care and point-of-donor testing is nudging suppliers to design more compact, interoperable systems that can be deployed in clinic-level settings. Regulatory frameworks and reimbursement pathways are also evolving in tandem, creating new pathways for clinical adoption while imposing higher expectations for clinical evidence and post-market surveillance. Finally, supply chain resiliency and environmental sustainability have emerged as strategic priorities, influencing material selection for kits and accessories and prompting manufacturers to rethink logistics and vendor relationships. Together, these shifts are accelerating the transition from isolated product sales to integrated service and solution offerings that combine devices, consumables, and data-driven support.

Examining the operational and strategic consequences of tariff-driven import pressures on supply chains, sourcing choices, and procurement timelines across the ecosystem

The policy environment influencing apheresis equipment procurement has changed materially due to tariff measures enacted in recent policy cycles, prompting organizations to reassess sourcing, inventory, and manufacturing footprints. Tariff-driven cost pressures on imported components and finished systems have increased emphasis on supplier diversification and nearshoring strategies, with procurement teams evaluating trade-offs between unit price, delivery certainty, and long-term vendor reliability. For many stakeholders, this has translated into a more deliberate approach to supplier qualification, with greater scrutiny of component origin, supplier financial resilience, and contractual protections against future trade disruption.

Clinicians and hospital procurement functions have responded by extending inventory lead times for critical consumables, especially single-use kits and accessories that are susceptible to supply chain variability. At the same time, manufacturers have accelerated efforts to secure alternative supply sources, invest in localized manufacturing capacity where feasible, and redesign packaging and logistics to mitigate tariff impacts. These adaptations have also affected how research institutes and commercial entities plan clinical programs: extended lead times for specialized cell separator systems or pathogen inactivation consumables necessitate earlier procurement planning and contingency reserves.

Regulatory and compliance teams have had to reconcile the operational need to diversify sources with local registration requirements and quality assurance standards, ensuring that alternate suppliers meet the same clinical and safety benchmarks. In aggregate, tariff pressures have nudged the ecosystem toward greater supply-chain transparency, increased inventories for critical SKUs, and closer collaboration between device manufacturers, component suppliers, and end users to preserve continuity of care and clinical research timelines.

Detailed segmentation analysis revealing how product categories, clinical applications, end user profiles, and technology choices intersect to drive differentiation and value

Understanding the apheresis equipment landscape requires a granular view across product types, applications, end users, technologies, and patient populations, each of which shapes purchasing logic and clinical deployment. Product distinctions between apheresis kits and accessories, cell separator systems, pathogen inactivation systems, and plasma separation systems drive different procurement cycles and revenue models; consumables such as single-use kits often underpin recurring revenue streams and demand well-established logistics, whereas capital-intensive separators require long-term service and training investments. Application-level segmentation further refines this dynamic: cell collection activities, encompassing both CAR T cell collection and stem cell collection, demand systems optimized for cell viability, processing speed, and closed-system workflows, while plasma donation pathways-ranging from single donor plasma to source plasma-prioritize throughput, donor comfort, and pathogen reduction capabilities. Research use and therapeutic apheresis each impose specific documentation and performance expectations that influence device configuration and aftermarket support.

End users present another axis of differentiation. Blood centers operate at scale with repeatable donor flows and stringent regulatory reporting, clinics often seek compact, user-friendly platforms to support lower-volume programs, and hospitals-whether general or specialty-balance a mix of acute care needs with procedural throughput considerations. Research institutes, divided into academic and commercial entities, demand specialized interfaces for experimental protocols and close collaboration with manufacturers on validation and customization. On the technology front, centrifugal and membrane approaches offer distinct trade-offs: centrifugal platforms, available in full automation and semi-automation variants, generally emphasize closed-system handling and established clinical ergonomics, while membrane-based systems, including batch and continuous flow formats, can offer modularity and different performance envelopes for specific applications. Finally, patient type segmentation between adult and pediatric populations affects device settings, consumable sizing, and clinical training priorities, requiring manufacturers and providers to tailor protocols and support materials accordingly. Synthesizing these segmentation layers enables targeted product development and commercially viable service strategies that match clinical realities.

Regional nuances in infrastructure, regulation, and clinical focus that determine adoption curves, procurement behavior, and partnership needs across global markets

Regional dynamics significantly shape how apheresis equipment is adopted, supported, and scaled, with differences rooted in healthcare infrastructure, regulatory regimes, donation models, and clinical focus areas. In the Americas, robust clinical networks, a high prevalence of cell therapy trials, and established blood center infrastructures create natural demand for advanced cell separator systems and integrated consumable supply chains. Procurement processes in this region tend to emphasize vendor service capabilities, clinical training programs, and evidence of operational reliability across high-throughput centers. Conversely, Europe, the Middle East & Africa features a more heterogeneous landscape where regulatory harmonization, national blood service models, and variable healthcare spending influence adoption patterns; centralized health systems and national procurement mechanisms often favor standardized platforms and long-term service arrangements, while emerging markets within the region require cost-optimized solutions and flexible deployment models.

Asia-Pacific presents a diverse mix of opportunities and constraints: major metropolitan centers and research hubs are rapidly building capacity for cell therapy programs and high-volume plasma collection, driving demand for both automated separators and pathogen inactivation technologies. At the same time, differences in regulatory timelines, local manufacturing incentives, and reimbursement frameworks create a patchwork of adoption speeds across countries. Across all regions, localization of supply chains, clinical training, and aftermarket service capabilities remain critical for sustained adoption. Regional stakeholders increasingly prioritize partnerships that deliver not just equipment but a comprehensive package of training, consumable supply assurance, and data-driven support to optimize clinical throughput and donor safety.

How technology differentiation, consumable ecosystems, and service excellence determine competitive advantage and partnership priorities among equipment suppliers

Competitive dynamics among device manufacturers, consumable suppliers, and service providers are defined by a combination of technological differentiation, aftermarket revenue focus, and clinical support capabilities. Market leaders tend to invest heavily in consumables ecosystems-single-use kits and accessories-that lock in recurring demand and create high switching costs for end users. At the same time, differentiation through software tools, automation levels, and integrated clinical support services is becoming a decisive factor in procurement discussions, as hospitals and blood centers seek vendors that can reduce operator variability and streamline training.

Collaboration between manufacturers and research institutes is accelerating innovation cycles, especially for cell collection systems tailored to CAR T and stem cell protocols. Strategic partnerships, co-development agreements, and clinical trial support arrangements help bridge the gap between laboratory methods and scalable clinical workflows. Additionally, companies that offer robust global service networks, including local parts availability and responsive technical support, gain competitive advantage in markets where uptime is directly linked to clinical throughput and donor retention. Longer-term strategies increasingly include investments in localized manufacturing, modular product architectures that permit incremental upgrades, and sustainability initiatives to reduce the environmental footprint of consumables and packaging. Collectively, these approaches shape a competitive environment where technical performance, service quality, and supply security matter as much as device specifications.

Actionable strategic priorities for manufacturers and providers to strengthen supply resilience, accelerate clinical adoption, and capture recurring revenue streams

Industry leaders should adopt a multifaceted strategy that balances near-term operational resilience with long-term innovation to capture clinical and commercial opportunities. First, prioritize supply chain transparency and redundancy for critical consumables by qualifying multiple suppliers, optimizing inventory policies for single-use kits, and evaluating regional manufacturing or tolling options to mitigate import-related disruptions. Second, invest in automation and software capabilities that reduce operator variability and shorten training cycles, thereby improving throughput and clinical consistency for both cell collection and plasma donation workflows. Third, develop modular product architectures that allow customers to upgrade functionality-such as pathogen inactivation modules or enhanced data interfaces-without full system replacement, increasing lifetime value and easing procurement decisions.

Additionally, strengthen clinical partnerships by supporting investigator-initiated trials and co-development programs with academic and commercial research institutes; these collaborations accelerate validation of novel protocols and create a pipeline of evidence that underpins adoption. For commercial strategy, align pricing models with end-user economics by offering bundled options that combine capital equipment, consumable subscriptions, and performance-based service commitments. From a regulatory perspective, harmonize submissions across key jurisdictions and prepare robust post-market surveillance strategies to meet evolving safety expectations. Finally, embed sustainability and circular-economy considerations into product design and logistics planning to address growing environmental and procurement requirements, while communicating these efforts clearly to customers as a differentiator in institutional purchasing decisions.

A rigorous triangulation of clinical interviews, technical documentation, regulatory records, and procurement analysis to ensure evidence-based insights and operational relevance

The analysis underpinning this executive summary combined primary and secondary evidence tailored to the technical and operational characteristics of apheresis equipment. Primary research included structured interviews with clinical users across hospitals, blood centers, clinics, and research institutes, as well as discussions with device engineers, supply chain managers, and regulatory specialists to capture real-world deployment challenges and vendor performance considerations. Secondary research encompassed device manuals, regulatory filings, clinical trial registries, peer-reviewed literature, and technical white papers to validate performance claims, trace technology evolution, and assess compatibility with clinical protocols.

Supplementary inputs included analyses of procurement patterns and service models, review of patent landscapes to identify innovation trends, and examination of policy and trade developments affecting component sourcing and logistics. Where applicable, technical specifications were compared across centrifugal and membrane platforms to understand automation capabilities and consumable footprints. All findings were triangulated through cross-validation from multiple sources to ensure reliability and relevance for decision-makers. Throughout the research process, emphasis was placed on clinical applicability and operational feasibility rather than speculative projections, resulting in insights designed to inform procurement, R&D prioritization, and strategic partnerships.

Synthesis of clinical, technological, and operational imperatives that define the path to durable adoption and commercial success in apheresis equipment

The collective insights reveal an apheresis ecosystem in transition: technological advances and clinical demand are spurring new system capabilities and service models, while policy and supply chain pressures are reshaping procurement and manufacturing choices. The convergence of automation, improved pathogen control, and tailored consumable design is enabling safer, more efficient workflows that support both high-throughput plasma collection and delicate cell therapy harvests. At the same time, tariff-driven import dynamics and regional regulatory variability underscore the need for proactive supply chain strategies and localized support capabilities.

For stakeholders across the value chain, the imperative is clear: align product development with clinical workflows, secure recurring consumable revenue through reliable logistics and training, and invest in partnerships that accelerate clinical validation. By combining technical performance with robust service offerings and supply continuity, manufacturers and providers can deliver solutions that meet both immediate operational needs and long-term clinical goals. The path forward favors organizations that think holistically about devices as part of an ecosystem encompassing consumables, software, clinical evidence, and service.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of automated cell processing and AI-driven optimization in apheresis workflows
  • 5.2. Rising demand for convalescent plasma collection devices amid global health crises
  • 5.3. Shift toward portable and point-of-care apheresis systems for remote or mobile settings
  • 5.4. Growing utilization of single-use disposable kits to reduce cross-contamination risks
  • 5.5. Expansion of emerging apheresis markets in Asia-Pacific driven by supportive healthcare policies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Apheresis Equipment Market, by Product Type

  • 8.1. Apheresis Kits & Accessories
  • 8.2. Cell Separator Systems
  • 8.3. Pathogen Inactivation Systems
  • 8.4. Plasma Separation Systems

9. Apheresis Equipment Market, by Application

  • 9.1. Cell Collection
    • 9.1.1. Car T Cell Collection
    • 9.1.2. Stem Cell Collection
  • 9.2. Plasma Donation
    • 9.2.1. Single Donor Plasma
    • 9.2.2. Source Plasma
  • 9.3. Research Use
  • 9.4. Therapeutic Apheresis

10. Apheresis Equipment Market, by End User

  • 10.1. Blood Centers
  • 10.2. Clinics
  • 10.3. Hospitals
    • 10.3.1. General Hospitals
    • 10.3.2. Specialty Hospitals
  • 10.4. Research Institutes
    • 10.4.1. Academic Institutes
    • 10.4.2. Commercial Institutes

11. Apheresis Equipment Market, by Technology

  • 11.1. Centrifugal Technology
    • 11.1.1. Full Automation Systems
    • 11.1.2. Semi Automation Systems
  • 11.2. Membrane Technology
    • 11.2.1. Batch Systems
    • 11.2.2. Continuous Flow Systems

12. Apheresis Equipment Market, by Patient Type

  • 12.1. Adult
  • 12.2. Pediatric

13. Apheresis Equipment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Apheresis Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Apheresis Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Terumo Blood and Cell Technologies, Inc.
    • 16.3.2. Haemonetics Corporation
    • 16.3.3. Fresenius Kabi AG
    • 16.3.4. Macopharma S.A.S.
    • 16.3.5. B. Braun Melsungen AG
    • 16.3.6. Miltenyi Biotec GmbH
    • 16.3.7. Grifols, S.A.
    • 16.3.8. Asahi Kasei Medical Co., Ltd.
    • 16.3.9. Cerus Corporation
    • 16.3.10. Fenwal, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. APHERESIS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. APHERESIS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. APHERESIS EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PA